Adele Gautier: Breast Cancer Foundation researcher discusses Pharmac consideration of switch to Herzuma
Early Edition with Ryan Bridge - Podcast tekijän mukaan Newstalk ZB
Changes are on the cards for some breast cancer patients. Pharmac is consulting on a drug switch proposal to replace the current expired one. Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it. Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby. LISTEN ABOVESee omnystudio.com/listener for privacy information.